![](https://thumb.spokesman.com/q4QApqCks443Zi45pHxG7lPVb74=/1200x630/smart/media.spokesman.com/photos/2024/07/12/6691ba10aca35.image.png)
Third FDA-approved Alzheimer’s drug can give patients more time with family
Alzheimer’s patients can temporarily lessen their symptoms with a recent FDA-approved drug that removes amyloid, or protein, plaques in the brain. The drug, donanemab, was developed by pharmaceutical company Eli Lilly and is marketed under the name Kinusla …